MYC and acute myeloid leukemia: These findings, if substantiated in AML patient cohorts, suggest that epigenetic stratification of AML patients based on identification of a functional MYC SE, as measured by eRNA expression, may provide a viable approach to predict patient response to NR4A-directed therapy.